Results overview: Found 4 records in 0.01 seconds.
Articles, 3 records found
Research literature, 1 records found
Articles 3 records found  
1.
22 p, 7.9 MB Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program / Janin, M. (Cancer Epigenetics and Biology Program (PEBC). Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; Ortiz-Barahona, V. (Cancer Epigenetics and Biology Program (PEBC). Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; de Moura, M.C. (Cancer Epigenetics and Biology Program (PEBC). Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; Martínez-Cardús, A. (Cancer Epigenetics and Biology Program (PEBC). Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; Llinàs-Arias, P. (Cancer Epigenetics and Biology Program (PEBC). Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; Soler, Marta (Cancer Epigenetics and Biology Program (PEBC). Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; Nachmani, D. (Department of Medicine and Pathology. Cancer Research Institute. Beth Israel Deaconess Cancer Center. Beth Israel Deaconess Medical Center. Harvard Medical School) ; Pelletier, J. (Molecular Mechanisms and Experimental Therapy in Oncology Program. Metabolism and Cancer Group. Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; Schumann, U. (EMBL-Australia Collaborating Group. Department of Genome Sciences. The John Curtin School of Medical Research. The Australian National University) ; Calleja-Cervantes, M.E. (Cancer Epigenetics and Biology Program (PEBC). Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; Moran, Sebastian (Cancer Epigenetics and Biology Program (PEBC). Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; Guil, S. (Cancer Epigenetics and Biology Program (PEBC). Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; Bueno-Costa, A. (Cancer Epigenetics and Biology Program (PEBC). Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; Piñeyro, D. (Cancer Epigenetics and Biology Program (PEBC). Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; Perez-Salvia, M. (Cancer Epigenetics and Biology Program (PEBC). Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; Rosselló-Tortella, M. (Cancer Epigenetics and Biology Program (PEBC). Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; Piqué, L. (Cancer Epigenetics and Biology Program (PEBC). Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; Bech-Serra, J.J. (Proteomics Unit. Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; De La Torre, C. (Proteomics Unit. Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet) ; Vidal, A. (Centro de Investigacion Biomedica en Red Cancer (CIBERONC)) ; Martínez-Iniesta, M. (Program Against Cancer Therapeutic Resistance (ProCURE). Catalan Institute of Oncology (ICO). Bellvitge Institute for Biomedical Research (IDIBELL). Oncobell Program. L'Hospitalet del Llobregat) ; Martín-Tejera, J.F. (Program Against Cancer Therapeutic Resistance (ProCURE). Catalan Institute of Oncology (ICO). Bellvitge Institute for Biomedical Research (IDIBELL). Oncobell Program. L'Hospitalet del Llobregat) ; Villanueva, A. (Program Against Cancer Therapeutic Resistance (ProCURE). Catalan Institute of Oncology (ICO). Bellvitge Institute for Biomedical Research (IDIBELL). Oncobell Program. L'Hospitalet del Llobregat) ; Arias, A. (VHIO) ; Cuartas, I. (VHIO) ; Aransay, A.M. (Centro de Investigación Bimédica en Red de Enfermedades hepáticas y Digestivas (CIBERehd). CIC bioGUNE) ; La Madrid, A.M. (Pediatric Neuro-Oncology Unit. Department of Pediatric Hematology and Oncology. Hospital Sant Joan de Déu) ; Carcaboso, A.M. (Preclinical Therapeutics and Drug Delivery Research Program. Fundacio Sant Joan de Deu) ; Santa-Maria, V. (Pediatric Neuro-Oncology Unit. Department of Pediatric Hematology and Oncology. Hospital Sant Joan de Déu) ; Mora, J. (Department of Pediatric Hematology and Oncology. Hospital Sant Joan de Déu) ; Fernandez, A.F. (Institute of Oncology of Asturias (IUOPA). Instituto de Investigación Sanitaria del Principado de Asturias (ISPA-FINBA)) ; Fraga, M.F. (Nanomaterials and Nanotechnology Research Center (CINN-CSIC). Universidad de Oviedo-Principado de Asturias) ; Aldecoa, I. (Pathology-Brain Bank. Hospital Clínic de Barcelona-CDB-August Pi i Sunyer Biomedical Research Institute (IDIBAPS)) ; Pedrosa, L. (Glioma and Neural Stem Cell Group and Translational Genomics and Targeted Therapeutics in Solid Tumors Team. IDIBAPS) ; Graus Ribas, Francesc (Clinical and Experimental Neuroimmunology. IDIBAPS) ; Vidal, N. (Department of Pathology. Hospital Universitari de Bellvitge. IDIBELL. L'Hospitalet del Llobregat) ; Martínez-Soler, F. (Faculty of Medicine and Health Sciences-Bellvitge. Universitat de Barcelona. IDIBELL. L'Hospitalet del Llobregat) ; Tortosa, A. (Faculty of Medicine and Health Sciences-Bellvitge. Universitat de Barcelona. IDIBELL. L'Hospitalet del Llobregat) ; Carrato, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Balañá, Carmen (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Boudreau, M.W. (Department of Chemistry. University of Illinois at Urbana-Champaign) ; Hergenrother, P.J. (Department of Chemistry. University of Illinois at Urbana-Champaign) ; Kötter, P. (Institute for Molecular Biosciences. Goethe University) ; Entian, K.D. (Institute for Molecular Biosciences. Goethe University) ; Hench, J. (Division of Neuropathology. Institute of Medical Genetics and Pathology. University Hospital Basel) ; Frank, S. (Division of Neuropathology. Institute of Medical Genetics and Pathology. University Hospital Basel) ; Mansouri, S. (Division of Neurosurgery. Toronto Western Hospital. University of Toronto) ; Zadeh, G. (Division of Neurosurgery. Toronto Western Hospital. University of Toronto) ; Dans, P.D. (Joint IRB-BSC Program on Computational Biology. Institute for Research in Biomedicine (IRB Barcelona). The Barcelona Institute of Science and Technology (BIST)) ; Orozco, M. (Department of Biochemistry and Biomedicine. University of Barcelona) ; Thomas, G. (Division of Hematology/Oncology. Department of Internal Medicine. University of Cincinnati Medical School) ; Blanco, S. (Molecular Mechanisms Program. Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer. Consejo Superior de Investigaciones Científicas (CSIC). University of Salamanca) ; Seoane, J. (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Preiss, T. (Victor Chang Cardiac Research Institute) ; Pandolfi, P.P. (Department of Medicine and Pathology. Cancer Research Institute. Beth Israel Deaconess Cancer Center. Beth Israel Deaconess Medical Center. Harvard Medical School) ; Esteller, M. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
Tumors have aberrant proteomes that often do not match their corresponding transcriptome profiles. One possible cause of this discrepancy is the existence of aberrant RNA modification landscapes in the so-called epitranscriptome. [...]
2019 - 10.1007/s00401-019-02062-4  
2.
18 p, 2.0 MB A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples / Esteve-Codina, Anna (Centre de Regulació Genòmica) ; Arpi, Oriol (Institut Hospital del Mar d'Investigacions Mèdiques) ; Martinez-García, Maria (Hospital del Mar. Oncologia mèdica) ; Pineda, Estela (Hospital Clínic. Oncologia mèdica) ; Mallo, Mar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Gut, Marta (Centre de Regulació Genòmica) ; Carrato, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Rovira, Anna (Institut Hospital del Mar d'Investigacions Mèdiques) ; Lopez, Raquel (Hospital Universitari de Girona Doctor Josep Trueta) ; Tortosa, Avelina (Universitat de Barcelona, Departament d'Infermeria Fonamental) ; Dabad, Marc (Centre de Regulació Genòmica) ; Del Barco, Sonia (Institut Català d'Oncologia) ; Heath, Simon (Centre de Regulació Genòmica) ; Bagué, Silvia (Institut d'Investigació Biomèdica Sant Pau) ; Ribalta, Teresa (Hospital Clínic i Provincial de Barcelona) ; Alameda, Francesc (Hospital del Mar (Barcelona, Catalunya)) ; de la Iglesia, Nuria (Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS)) ; Balañá, Carmen (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; on behalf of the GLIOCAT Group ; Glioma Catalonia Group (GLIOCAT) ; Universitat Autònoma de Barcelona
The molecular classification of glioblastoma (GBM) based on gene expression might better explain outcome and response to treatment than clinical factors. Whole transcriptome sequencing using next-generation sequencing platforms is rapidly becoming accepted as a tool for measuring gene expression for both research and clinical use. [...]
2017 - 10.1371/journal.pone.0170632
PloS one, 2017, p. 1-18  
3.
12 p, 1.0 MB Estudio comparativo entre las areniscas paleozoicas y triásicas de la isla de Menorca : evidencias de procesos de reciclado / Arribas Mocoroa, José (Universidad Complutense de Madrid. Departamento de Petrología y Geoquímica) ; Gómez-Gras, David (Universitat Autònoma de Barcelona. Departament de Geologia) ; Rosell Sanuy, Joan (Universitat Autònoma de Barcelona. Departament de Geologia) ; Tortosa, A. (Universidad Complutense de Madrid. Departamento de Petrología y Geoquímica)
Resum.
1990
Revista de la Sociedad Geológica de España, Vol. 3 Num. 1-2 (1990) , p. 105-116  

Research literature 1 records found  
1.
22 p, 259.0 KB La Pacificación en el mundo actual : estrategias europeas para la resolución de conflictos / Tortosa Garrigós, María Amparo
¿Cómo se podría comprometer la Comunidad Internacional, en un mundo globalizado, para la resolución de conflictos?. En el siglo XXI, pasa necesariamente por un cuestionamiento de los métodos tradicionalmente empleados para la resolución de conflictos y la seguridad (frente a nuevos escenarios nuevas estrategias). [...]
Com es podria comprometre la comunitat Internacional, en un món globalitzat, per a la resolució de conflictes?. Al segle XXI, passa necessàriament per un qüestionament dels mètodes tradicionalment emprats per a la resolució de conflictes i la seguretat (enfront de nous escenaris noves estratègies). [...]

Institut Universitari d'Estudis Europeus 2002 (Working Papers OBS ; 31)  

See also: similar author names
3 Tortosa, Avelina
3 Tortosa, Avelina
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.